Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Groups

Publications

  • Leon, Alicia; McAlpine, Jessica N.; Nout, Remi; McConechy, Melissa K.; Ganesan, Raji; Matias-Guiu, Xavier; Oliva, Esther; Harrison, Beth T.; Soslow, Robert; Church, David; Gilks, C. Blake; Bosse, Tjalling

    Clinicopathological Characterization of Endometrial Carcinomas with More Than One Molecular Classifying Feature

    Modern Pathology 31 434-434. .

  • Segura, SE; Bi, R; Kumar, R; Vidal, A; Gatius, S; Abu-Rustum, N; Matias-Guiu, X; DeLair, D; Weigelt, B

    Hotspot TERT Promoter Mutations in Adult-Type Granulosa Cell Tumors of the Ovary as Potential Drivers of Progression

    LABORATORY INVESTIGATION 98 451-451. .

  • Segura, Sheila E.; Bi, Rui; Kumar, Rahul; Vidal, August; Gatius, Sonia; Abu-Rustum, Nadeem; Matias-Guiu, Xavier; DeLair, Deborah; Weigelt, Britta

    Hotspot TERT Promoter Mutations in Adult-Type Granulosa Cell Tumors of the Ovary as Potential Drivers of Progression

    Modern Pathology 31 451-451. .

  • Oaknin, A; Guarch, R; Barretina, P; Hardisson, D; Gonzalez-Martin, A; Matias-Guiu, X; Perez-Fidalgo, A; Vieites, B; Romero, I; Palacios, J

    Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 274-285. .

    [doi:10.1007/s12094-017-1719-x]

  • Van Der Putten L.J.M.; Visser N.C.M.; van de Vijver, K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Garcia, A; Mancebo, G; Alameda, F; Trovik, J; Kopperud, RK; Huvila, J; Schrauwen, S; Koskas, M; Walker, F; Weinberger, V; Minar, L; Jandakova, E; Snijders M.P.L.M.; van den Berg-van Erp, S; Matias-Guiu, X; Salvesen, HB; Werner H.M.J.; Amant, F; Massuger L.F.A.G.; Pijnenborg J.M.A.

    Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28 514-523. .

    [doi:10.1097/IGC.0000000000001187]

  • Matias-Guiu, X; Stewart CJR

    Endometriosis-associated ovarian neoplasia

    Pathology 50 190-204. .

    [doi:10.1016/j.pathol.2017.10.006]

  • Gatius, S; Cuevas, D; Fernandez, C; Roman-Canal, B; Adamoli, V; Piulats, JM; Eritja, N; Martin-Satue, M; Moreno-Bueno, G; Matias-Guiu, X

    Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology 85 35-40. .

    [doi:10.1159/000475529]

  • Martinez-Garcia, E; Lopez-Gil, C; Campoy, I; Vallve, J; Coll, E; Cabrera, S; Ramon Y Cajal, Santiago; Matias-Guiu, X; Van Oostrum, J; Reventos, J; Gil-Moreno, A; Colas, E

    Advances in endometrial cancer protein biomarkers for use in the clinic

    EXPERT REVIEW OF PROTEOMICS 15 81-99. .

    [doi:10.1080/14789450.2018.1410061]

  • Oaknin A.; Guarch R.; Barretina P.; Hardisson D.; González-Martín A.; Matías-Guiu X.; Pérez-Fidalgo A.; Vieites B.; Romero I.; Palacios J.

    Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 51 84-96. .

    [doi:10.1016/j.patol.2017.11.002]

  • Santaballa, A; Matias-Guiu, X; Redondo, A; Carballo, N; Gil, M; Gomez, C; Gorostidi, M; Gutierrez, M; Gonzalez-Martin, A

    SEOM clinical guidelines for endometrial cancer (2017)

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 29-37. .

    [doi:10.1007/s12094-017-1809-9]

  • Eritja, N; Jove, M; Fasmer, KE; Gatius, S; Portero-Otin, M; Trovik, J; Krakstad, C; Sol, J; Pamplona, R; Haldorsen, IS; Matias-Guiu, X

    Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget 8 109018-109026. .

    [doi:10.18632/oncotarget.22558]

  • Depreeuw, J; Stelloo, E; Osse, EM; Creutzberg, CL; Nout, RA; Moisse, M; Garcia-Dios, DA; Dewaele, M; Willekens, K; Marine, JC; Matias-Guiu, X; Amant, F; Lambrechts, D; Bosse, T

    Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

    CLINICAL CANCER RESEARCH 23 7232-7241. .

    [doi:10.1158/1078-0432.CCR-17-0566]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment